PROFILE
Holista Colltech Ltd is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients. Holista, listed on the Australian Stock Exchange (ASX:HCT), researches, develops, manufactures and markets health-style products to address the unmet and growing needs of natural medicine.
The mission of Holista Colltech Ltd is to provide society with all natural health-style products through innovations that advances the eminence of life and meeting customer needs, providing employees with momentous work environment and advancement opportunities, enhancing partner′s business and investors with a greater rate of return.
RESEARCH AND
DEVELOPMENT
Holista has a suite of food ingredients which does not compromise on taste, odor and mouth-feel. This includes low-Glycemic Index (“GI”) baked products, low sodium salt, low fat fried foods and low calories sugar.
On 12 January 2016 Holista announced that its GI-reducer PANATURA®GI achieved a scientific breakthrough by receiving the world’s lowest GI for “clean-label” white bread. Holista subsequently announced that it also achieved the lowest clean-label reading for the muffins category at GI Labs, a nutrition research organization in Toronto, Canada.
On 12 July 2016, Holista announced that it had entered into a joint-venture partnership with Nadja Foods LLC — headed by celebrity food expert, Nadja Piatka — to promote low-GI ingredient for white bread and baked products for North America.
Holista Colltech is the only company to produce sheep (ovine) collagen using patented extraction methods from Australia, and is on track to create a version of ovine collagen with a high absorption rate.
We aim to build a world class company focused on providing consumers with scientifically enhanced, engineered and tested natural health supplements and consumer products.
OUR TEAM
BOARD OF DIRECTORS
Mr Lai, a Singaporean, has nearly 40 years’ experience in international journalism, investment banking and communications
After military service in Singapore, he graduated from the National University of Singapore with a degree in arts and social science. He subsequently obtained a post-graduate diploma in Journalism from The City University of London while on a scholarship from Reuters, the international news agency. He has worked as a foreign correspondent in Singapore, Beijing, New Delhi and Kuala Lumpur (where he was Chief Correspondent for Malaysia and Brunei for Reuters). After a decade in journalism, he joined Merrill Lynch as head of equity research for Malaysia for the U.S. investment bank.
In 1999, he founded the WeR1 group, which offers consultancy services for investor relations, including IPOs, and crisis communications. He has handled complex corporate crisis situations in Asia and is regularly consulted by business leaders for corporate strategy. Many of his clients have won awards for investor relations.
In 2015 Singapore-registered WeR1 Consultants Pte, of which Mr Lai is Managing Director, was appointed as the first Asian member of the prestigious London-based Crisis & Litigation Communicators Alliance (CLCA).
Lai Kwok Kin
Chairman (Non-Executive, Independent)
With a Bachelor of Science degree in Mechanical Engineering from the United States, Mr. Leong brings extensive expertise in corporate management, financial oversight, and business development. His proven track record includes driving operational improvements and delivering results in complex environments.
Mr. Leong is an accomplished entrepreneur and inventor with 30 years of specialization in: Nanotechnology Green Chemistry, and Environmental Technology. He holds numerous patents and has contributed significantly to advancements in air purification, environmental sustainability, and material recycling across several global industries.
Currently, Mr. Leong also serves as the Executive Chairman of the Malaysia-headquartered SHEPROS Group of Companies, where he continues to innovate and lead projects that align with the latest in environmental and technological developments. With his executive leadership, the Board believes that Holista is well-positioned to navigate current challenges and work towards a sustainable and profitable future.
Leong Man Loong
Executive Director and Interim CEO
Mr. Pilant is the founder, CEO, and Chairman of Regenerex Pharma, Inc., which is listed on the OTCB in the United States, as well as of several other private companies. A life-long entrepreneur, he established Greystone Pharmaceuticals, Inc., and has led various medical and pharmaceutical firms since 1985, including Stanley Pharmaceuticals, National Labs, and MedStat.
With over 30 years of experience in wound care, Mr. Pilant has been instrumental in setting up related manufacturing facilities across the United States, China, Europe, and the Middle East. His expertise spans FDA and CE compliance, reimbursement, manufacturing, and distribution. Notably, he was among the first fifteen individuals inducted into the University of Memphis Business Hall of Fame.
Greg Pilant
Non-Independent, Non-Executive Director
Based in Perth, Mr. Gemelli is a dynamic entrepreneur and accomplished business operator with a proven track record across multiple industries. He began his career in the insurance sector at Federation Insurance, quickly rising to a management position.
Transitioning to the entertainment industry, he collaborated with Entertainment Enterprises Pty Ltd, eventually becoming General Manager of the Group. He later established his own entertainment business in Broome, Western Australia, which he sold at a profit.
An active investor, he is well versed with the regulations of the Australian Securities Exchange and companies listed there.
Robert Gemelli
Independent, Non-Executive Director
A business consultant based in Melbourne, Mr. Yee has held roles in multinational organisations, specializing in pharmaceuticals, diagnostics, and wellness. As CEO of Gribbles Diagnostic, he achieved revenue and profit growth over three years by re-engineering the organization and improving staff productivity
At Wyeth, he doubled sales between 2007 and 2009 and introduced impactful CSR initiatives such as Wyeth Aid. At Pfizer, he managed the COX-2 drug withdrawal crisis and, as Asia Pacific Marketing Director, refined regional business plan. His roles at Merck Serono, Beacon International, and Envy Continent (a wellness tourism venture he founded) underscored versatility in business model implementation and strategic articulation. Earlier, at GlaxoSmithKline and Roche, he secured significant government tenders and elevated brands to market leadership.
Mr. Yee holds a Bachelor of Pharmacy from the University of Wales and an MBA from the University of Strathclyde.
Sam Yee
Independent, Non-Executive Director
ADVISORS
Graduated University of Michigan with a Masters of Public Health, both bachelor's and Doctor of Veterinary Medicine degrees from Tuskegee University, an honorary Doctor of Science in 1990 from Tuskegee University, and a Doctor of Epidemiology from Johns Hopkins University.
Served as Assistant U.S. Surgeon General & Rear Admiral of U.S. Public Health Service.
Served as the Chief Epidemiologist with the Center for Device and Radiological Health at the U.S. FDA.
Served as the Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC.
Dr. Roscoe Moore
Graduated University of Bombay with a BSc (Tech) Food Technology, a Masters of Human Nutrition, a Doctor of Human Nutrition from London School of Hygiene and Tropical Medicine, University of London.
Served as part of the General Scientific Advisory Committee member, UK Food Standards Agency.
Professor of Food & Human Nutrition at Oxford Brookes University (1997 - 2011).
Currently serving as the Director of Clinical Nutritional Sciences, Singapore Institute of Clinical Services.
One of the inventors of Holista Foods core innovations (three patents).
Prof Jeya Henry
Meiert J. Grootes of Veripan is a Swiss-Dutch entrepreneur. He comes from a family of chocolate manufacturers, representing its seventh generation in the food business. Grootes completed his studies at the University of Wageningen, Netherlands in 1986, graduating as an engineer of process technology (MSc.). He proceeded to further studies in business at Oekreal/GSBA, Zurich, and at the International Institute for Management Development (IMD), Lausanne. He is a seasoned company builder having been on the management team of various start-up companies.
In 1992, he incorporated his own company Panadoro Group together with two partners. Grootes is experienced in working at senior levels in a variety of international food companies. Since 1993, Grootes has been CEO of the VERIPAN AG, headquartered in Matzingen, Switzerland, a leading food design company (“think tank”) for the national and international food industry. Since January 2015 Grootes is also Managing Director of the Swiss Agro Food Innovation Park, Frauenfeld. Currently he is preparing the incorporation of an Agro Food Venture Capital Fund with European and Asian corporate investors.
Grootes has lived in different European countries and from 2010 till 2013 in Singapore. He is married, father of three adult children and fluent in six languages. In his leisure time, he is interested in international economics, intercultural relations, skiing, golf, and cooking pancakes in all international varieties.
Meiert J. Grootes
GROUP STRUCTURE
Business Divisions
